Julie Rosenthal, MD , FACC

General Statement of Disclosure:

OTHER FINANCIAL BENEFIT: King Pharmaceuticals, Inc. (now part of Pfizer - October 2010)(MODEST), Alnylam(MODEST)

View Full Disclosure